関連する実験動画
Updated: Jan 6, 2026
01:19
Mitral Valve Prolapse III: Nursing Management
Published on: June 19, 2025
252
マウスにおけるダブルマーカーによるモザイク分析
Hui Zong1, J Sebastian Espinosa, Helen Hong Su
1Department of Biological Sciences, Stanford University, Stanford, CA 94305, USA.
Cell
|May 11, 2005
まとめ
マウスのダブルマーカー (MADM) によるモザイク分析により,同時に細胞ラベリングと遺伝子ノックアウトが可能です. このテクニックは,細胞をin vivoで効率的にラベル付けし,小脳粒子の細胞祖先系統の決定などの発達上の運命を明らかにします.
科学分野:
- 発達生物学 発達生物学とは
- 遺伝学 遺伝学とは
- 神経科学は神経科学である.
背景:
- 細胞系統と遺伝子の機能を in vivo で研究するには,正確なラベリングと操作技術が必要です.
- 既存の方法は,特定の細胞集団の遺伝子を同時に標識し,ノックアウトする能力が欠けていることが多い.
研究 の 目的:
- 新しい方法である,ダブルマーカーによるモザイク分析 (MADM) を導入し,インビヴォで同時にラベリングと遺伝子ノックアウトを行う.
- 様々な細胞タイプと組織におけるMADMの効率性と広範な適用性を実証する.
- MADMを用いて,発達中の小脳における細胞運命を決定する過程を研究する.
主な方法:
- MADMは,同一の染色体位置にある2つの相互のキメリック遺伝子をノックする.
- 機能的マーカーの発現と再結合は,Cre recombinaseによって誘発されます.
- この方法は,系統追跡および遺伝子ノックアウト研究のために,体細胞の標識されたクローンの作成を可能にします.
主要な成果:
- MADMは,検査されたすべての組織におけるミトーシス細胞とポストミトーシス細胞の両方の染色体間再結合を効率的に誘導します.
- この研究では,小さな,ラベル付けされた細胞集団で条件付きノックアウトを成功裏に作成しました.
- MADMは,小脳粒子の細胞祖先が早期に特定され,その子孫は小脳皮質内の制限された軸索投影パターンを示すことを明らかにしました.
結論:
- MADMは,in vivo細胞ラベリング,遺伝子ノックアウト,系統追跡,およびニューロンの接続研究のための強力で汎用的なツールです.
- この方法は,脳小胞粒細胞の祖先の早期の運命決定によって例示される,発達過程に関する新しい洞察を提供します.
- MADMは,複雑な生物システムにおけるクローンレベルで遺伝子機能と細胞の行動を研究する能力を大幅に向上させています.
関連する概念動画
Mitral Valve Prolapse III: Nursing Management
252
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
252
Cancer Vaccines
917
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
917
Development of Immunocompetence
759
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
759
Vaccinations
51.1K
Overview
51.1K
Healthcare Associated Infections II: Preventive Measures
3.5K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.5K
Teratogenicity
3.9K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.9K